Close Menu

NEW YORK – Scope Fluidics said Tuesday that it has raised 14 million Polish zloty ($3.6 million) by issuing shares. The Warsaw, Poland-based biotechnology company will direct the funds to further development and commercialization of its PCR One molecular diagnostics system as well as its BacterOmic phenotypic antibiotic susceptibility testing system.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.